NCT06336148 2025-10-15A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsActym Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT05563272 2025-07-10STARBURSTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 2 Terminated11 enrolled
NCT02714374 2024-08-06GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersUniversity of California, San DiegoPhase 1 Terminated5 enrolled